The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · cited 1×
“Multidrug resistance is also emerging as the major problem in the conventional treatment of cancer [3].”
BackgroundPI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
Anti-cancer natural products isolated from chinese medicinal herbs
Tan, W., Lu, J., Huang, M., Li, Y., Chen, M., Wu, G., Gong, J., Zhong, Z., Xu, Z., Dang, Y., et al. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-27 · Cited by 396
Pickhardt, M., Gazova, Z., von Bergen, M., Khlistunova, I., Wang, Y., Hascher, A., Mandelkow, E.-M., Biernat, J., & Mandelkow, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410984200 · Cited by 333
Su, Y.-T., Chang, H.-L., Shyue, S.-K., & Hsu, S.-L. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.026 · Cited by 255
Chen, Y.-C., Shen, S.-C., Lee, W.-R., Hsu, F.-L., Lin, H.-Y., Ko, C.-H., & Tseng, S.-W. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01386-2 · Cited by 226
Srinivas, G., Anto, R. J., Srinivas, P., Vidhyalakshmi, S., Senan, V. P., & Karunagaran, D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01976-9 · Cited by 192
Emodin Down-Regulates Androgen Receptor and Inhibits Prostate Cancer Cell Growth
Cha, T.-L., Qiu, L., Chen, C.-T., Wen, Y., & Hung, M.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3250 · Cited by 178
Kumar, A., Dhawan, S., & Aggarwal, B. B. (1998) · Oncogene · doi:10.1038/sj.onc.1201998 · Cited by 163
Self-citation
Cited by
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Self-citationEmodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics
Dong, X., Fu, J., Yin, X., Cao, S., Li, X., Lin, L., Huyiligeqi, & Ni, J. (2016) · Phytotherapy Research · doi:10.1002/ptr.5631 · Cited by 762
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
Dong, X., Zeng, Y., Liu, Y., You, L., Yin, X., Fu, J., & Ni, J. (2020) · Phytotherapy Research · doi:10.1002/ptr.6532 · Cited by 591
Medicinal Plants, Human Health and Biodiversity: A Broad Review
Sen, T., & Samanta, S. K. (2014) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2014_273 · Cited by 330
M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds
Wang, Y., Smith, W., Hao, D., He, B., & Kong, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.050 · Cited by 330
Metadata
- Authors
- Shrimali, D., Shanmugam, M. K., Kumar, A. P., Zhang, J., Tan, B. K. H., Ahn, K. S., & Sethi, G.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 341
- Issue
- 2
- Pages
- 139-149
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2007086998
- Cited by
- 277
- References
- 66
- FWCI
- 24.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.